26 October 2020 – Ant Group Aims for World’s Biggest Floatation Topping $250bn

The Big Ones

Yuanfudao is the latest Chinese online education provider to raise a huge amount, reportedly securing $1bn in a series G2 round led by DST Global that valued it at $15.5bn post-money. Its earlier investors include Tencent, which co-led the company’s $1bn series G round in March at a $7.8bn valuation, and which was reported last month to be taking part in a $1.2bn round that media reports state had already closed in the run up to the series G2 funding.

Ant Group has secured regulatory approval for the Shanghai leg of a dual listing expected to raise some $35bn at a valuation that may top $250bn, having got clearance for the Hong Kong offering on Monday. Which would make it the biggest flotation in history. The financial services provider was valued at $150bn when it raised $14bn in its 2018 series C round, and Alibaba, which spun the company off, is set to buy about 20% of the shares being issued to come out with a 32% stake post-IPO.

The biggest fund this week is actually a crossover: UVC Partners, the Germany-based venture capital firm affiliated with Technical University of Munich (also known as TUM), unveiled its €150m ($178m) third fund on Tuesday backed by LPs including specialty chemicals company Lanxess. The co-founders of mobility services provider Flixbus also invested in the fund, as have a range of unnamed institutional investors, family offices, corporates and family businesses. UVC Partners maintains a close relationship with UnternehmerTUM, the university’s centre for innovation and business creation. The two entities actually share leadership in Helmut Schönenberger, who is the chief executive of UnternehmerTUM and a managing partner of UVC Partners.

Deal-wise, in crossover news, AavantiBio is the latest entrant to the genetic therapy space, launching on Thursday with $107m in series A funding, $15m of which came from genetic drug developer Sarepta Therapeutics. The spinout’s president and CEO had spent some eight years in an executive position at Sarepta and its core technology is based on University of Florida research. AavantiBio will concentrate on genetic therapeutics for rare diseases and its initial focus is on Friedreich’s Ataxia (FA), an inherited genetic disease that leads to central nervous system and cardiac dysfunction.

Deals

Google has reportedly invested $300m in Tokopedia, one of Southeast Asia’s largest e-commerce marketplaces, as part of a late-stage round already equipped with $500m from Temasek on its way to a targeted close around the $1bn mark. Tokopedia’s earlier investors include CyberAgent Capital, Alibaba and SoftBank vehicles Vision Fund, SoftBank Ventures Asia and SB Pan Asia Fund.

Shouqi Yueche is one of several companies that had seen funding drop off in the wake of China’s regulatory crackdown on its ride hailing sector, but it claims to have increased its registered users by more than 30% in the last year and has also pulled in ‘hundreds of millions of dollars’ in series C funding. The investors in the round have not been revealed but the company’s existing backers include Baidu and Nio Capital.

Arctic Wolf is one of the fastest rising operators in the cybersecurity scene, the cybersecurity concierge provider having raised $200m in a DTCP-backed series E round valuing it at $1.3bn. It had secured $60m in series D funding just seven months ago and its overall funding now stands at more than $350m. It is also moving its head office from California to Minnesota amidst plans to up headcount significantly.

Online education has thrived during the coronavirus pandemic but another Chinese company, online pharmacy operator Dingdang Kuaiyao, has also seen user numbers rise significantly. It has pulled in $150m through a series B-plus round that included existing backers Softbank China and Sinopharm-CICC Capital. Both had already taken part in the company’s $89m series B early last year.

VectivBio has closed a $110m crossover financing round that included Novo to advance its short bowel syndrome treatment through phase 3 clinical trials. The company was spun off from Therachon, a Novo-backed genetic disease therapy developer acquired for $810m in May last year. Novo had also been among the investors to provide the $35m VectivBio had when it launched in January this year.

Hyperscience has developed software that allows organisations to automate back-office tasks to increase efficiency, and has raised $80m in a series D round led by Tiger Global Management. The company’s earlier backers include QBE, TD Ameritrade and Penna and Company, and the series D round took its overall funding past the $190m mark.

Funds

Spain-based telecommunications firm Telefónica has launched a cybersecurity-focused investment vehicle called Telefónica Tech Ventures that expects to provide funding for 15 cybersecurity technology developers over the next three years, investing up to $7m per deal at series A to C stage. Follow-on funding will be available for the better performing recipients.

Exits

Big funding isn’t necessarily the fuel for success however, with short-form streaming service Quibi announcing yesterday it is set to shutter its platform, which launched just six months ago. It will have about $350m to return from the $1.75bn it raised from investors including Alibaba, Sony, 21st Century Fox, Walt Disney, WarnerMedia, Entertainment One and, reportedly, Google and Facebook. Quibi itself has blamed the coronavirus for much of its trouble getting subscribers, but the low adoption rate following free trials points to a lack of good programming and, perhaps deeper, to too many execs with TV experience and not enough with online expertise.

Quibi isn’t the only tech unicorn set to call it a day however. Chinese online car marketplace Renrenche has raised $760m from investors including Didi Chuxing and Tencent and was reportedly valued at $1.7bn after its most recent round in 2018, but Bloomberg has reported it is in talks to sell its major assets to 58.com for a token amount a little over $1,000. Renrenche’s branch of the startup space has been impacted heavily by the coronavirus, but it also competes in a crowded sector. These may be just the start of several parts of the startup space thinning out as revenues dip and money gets increasingly tight.

Back to some better news: although both the US and China have been hotbeds for tech IPOs in recent months, ride hailing has been visibly apart from that as the sector’s inhabitants look to offset the damage to their businesses done by the coronavirus. Dida Chuxing was recently reported to be mulling a Hong Kong IPO, and market leader Didi Chuxing is reportedly looking at the same destination for a 2021 offering. The purported IPO is expected to value Didi at up to $60bn and investors including SoftBank, Apple, Alibaba, China Life, Tencent, Booking Holdings, Ping An, eHi and Sina Weibo would be in line for exits.

Small molecule drug developer Aligos Therapeutics has raised $150m in an initial public offering that involved it pricing 10 million shares in the middle of their $14 to $16 range. Those shares are currently (that’s Friday afternoon UK time) at $15.12, but the offering nevertheless represents exits for Roche Finance and Novo, which were among the investors that had supplied more than $230m in venture funding for Aligos.

Advanced hearing aid provider Eargo on the other hand has celebrated a bumper IPO, floating above its range in an upsized offering to raise more than $141m, then seeing its shares open at double the IPO price on their first day of trading. You know who else must be celebrating? Nan Fung Life Sciences, which participated in Eargo’s last three rounds and which is now backing a company with a market cap over $1.2bn.

Compass Therapeutics is the latest drug developer to file for an initial public offering, though the $50m target it has set suggests its aim may be lower than most. The immuno-oncology therapy developer had secured $132m in a 2018 series A round featuring life sciences-focused real estate investment trusts Alexandria Real Estate Equities and Biomed Realty, but neither possess a stake in the company sized at 5% or greater.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

24 August 2020 – SpaceX Raises $1.9bn

The Big Ones

SpaceX has been one of the most fervent fundraisers among private companies in recent years and it shows no signs of stopping. A securities filing indicates the spacecraft manufacturer and launch services provider has secured $1.9bn from undisclosed investors, with recent media reports putting the valuation of the round at $46bn. Its earlier backers include Google, which invested $900m at a $12bn valuation five years ago, and that valuation looks set to keep on rising for now.

Consumer electronics manufacturer Konka Group has teamed up with the Chinese city of Yancheng to put together an industry fund that will begin investing from a base of about $435m. The fund will be sized at up to $1.45bn and Konka is providing 40% of the capital. Its areas of interest include AI, semiconductors, the internet-of-things, new machinery and advanced materials.

Airbnb has announced it has confidentially filed for its long-awaited initial public offering. People were talking about an Airbnb flotation before the last downturn in the IPO markets in 2018. The rebound last year wasn’t enough to tempt it, but now, while they’re rallying for tech stocks, seems to be the right time despite a coronavirus-related hit to Airbnb’s business that saw it lay off 25% of its staff in May. The CapitalG-backed company had been valued at $26bn, down from $31bn, when it raised $1bn in debt and equity the previous month.

We have finally hit that summer lull on GUV, but there were still a few big stories. Most notably, Mission Bio, a US-based DNA analysis technology spinout of University of California, San Francisco (UCSF), has raised $70m in a series C round led by pharmaceutical firm Novo’s Novo Growth unit. Agilent Ventures, the corporate venturing arm of laboratory equipment and diagnostics services provider Agilent Technologies, also took part in the round, as did Cota Capital, Mayfield Fund and Soleus Capital. The round took the company’s total funding to more than $120m, it said, and Robert Ghenchev, head of Novo Growth, has joined its board of directors. Founded in 2014, Mission Bio has created a system called Tapestri which enables researchers and medical professionals to analyse single-cell RNA sequencing data to help develop precision medicines. The spinout leverages genomics technology from UCSF’s Abate Lab.

Deals

E-commerce group JD.com”s pharmaceutical product and medical services spinoff JD Health raised $1bn at a $6.9bn valuation last year, and now it’s agreed to add series B funding from investment manager Hillhouse Capital. The deal is set to be finalised next month and JD Health expects to get upwards of $830m from Hillhouse, an investor in its parent company since its 2012 series C round.

Last week we talked about reports that Chinese online medical insurance and crowdfunding service Waterdrop had raised $200m at a $2bn valuation, but a subsequent announcement places the size of the round at $230m. Tencent and Swiss Re co-led the round, which sources told Reuters valued Waterdrop just short of $2bn. Swiss Re has been relatively quiet in the corporate venturing space in recent years but reportedly put up $100m of the capital in this round.

Online share trading has made a big jump as the stock markets rally, and RobinHood is getting a lot of business in the US market. It has accordingly increased its valuation from $8.3bn to $11.2bn in the space of just four weeks, its latest move being to raise $200m in series G financing from investment firm D1 Capital Partners. It has now secured a total of $1.7bn and its earlier investors include Roc Nation’s Arrive subsidiary as well as Alphabet units GV and CapitalG.

Palfish is one of several Chinese online education providers to have experienced growth during Covid-19 lockdowns, and it has raised $120m in a series C round that included quantitative trading firm Susquehanna International Group. The company specialises in English tutoring and claims to have some 40 million users. It will put the funding towards improving its big data technology.

BlockFi has been one of the more frequent fundraisers in the startup space having closed five rounds in just over two years as it expands its range of digital currency services. The latest is a $50m series C round that included subsidiaries of CM Group and Siam Commercial Bank. The company has now secured more than $160m and its earlier backers include Consensys, SIG, Recruit and SoFi.

There are several VC-backed companies operating under the moniker of Element but the latest to raise money is the Germany-based bespoke insurance software provider, which has added funding from investors including Sony Financial Ventures and SBI Investment to a series A round that now stands at $46.5m. The earlier tranches featured Signal Iduna and Mitsui Sumitomo Insurance.

Funds

MDI Ventures, the corporate venturing arm of Indonesian state-owned telecommunications firm Telkom, has closed a $500m fund entirely financed by the company. It will invest between $5m and $30m in domestic digital technology developers that will get access to a range of government-owned corporations, which in turn will be able to leverage the technology required to form a digital ecosystem in the country.

Russian conglomerate Sistema may not be the most active participant in the corporate venturing space but it does have one of the largest ranges of investment, having closed a series of funds focusing on different regions and sectors. Its Sistema Asia Capital subsidiary closed a $120m India fund in 2015 and is in the midst of raising the same amount for a vehicle concentrating on Southeast Asia. Areas of interest include cybersecurity, computer vision, smart cities, urban mobility and the internet-of-things.

Exits

Pharmaceutical companies Juno Therapeutics (itself a spinout of Fred Hutchinson Cancer Research Centre, Seattle Children’s Research Institute and Memorial Sloan-Kettering Cancer Centre) and WuXi AppTec founded cancer immunotherapy developer JW Therapeutics in 2016 and now it has filed for an initial public offering in Hong Kong. Recent reports suggested JW would target $250m to $300m in the IPO having already raised more than $200m in venture funding. Juno retains a 26% stake in the company while WuXi AppTec owns about 14% of its shares.

Biologic drug developer Inhibrx has gone public, raising $119m having floated at the midpoint of its range. Inhibrx had received some $135m in equity and debt financing from investors including Eli Lilly and WuXi Biologics, and its share price followed recent trends by rising post-IPO. It’s been a bumper time for newly public companies of late, the question is how much of a bubble this represents and whether latecomers to the party could end up missing out.

Nano-X Imaging is working on a medical imaging system intended to function as a more affordable alternative to X-ray machines, and the Israeli company has set terms for an initial public offering in the US that will raise almost $106m if it floats at the top of its range. A big impetus is that existing investors including corporates Foxconn, SK Telecom and iA Financial have expressed interest in buying up to $80m of shares in the offering, which is a more than decent vote of confidence.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

20 July 2020 – 5G & IoT Provider Jio Platforms Gains $4.5bn from Google

The Big Ones

Jio Platforms was spun off by Indian conglomerate Reliance Industries late last year to build a mobile network tailored for 5G and the internet of things, and everyone seems to want a slice. The latest is Google, which is paying $4.5bn for a 7.7% stake in Jio, the deal coming in the wake of parent company Alphabet’s recent pledge to invest some $10bn in India over the coming years. Qualcomm Ventures and Intel Capital had supplied a total of $350m for it earlier this month – Qualcomm’s actually came only a few days before Google’s investment. Meanwhile Facebook paid $5.7bn for a 10% stake in April.

Alphabet announced that it intends to channel up to $10bn into India through a newly formed vehicle dubbed Google for India Digitization Fund. That commitment will include equity funding for domestic companies, though as yet it’s unclear whether that will be deployed through the corporate’s investment subsidiaries. One of them, CapitalG, has already invested in several Indian companies but GV is yet to establish a presence in the region.

There’s been more IPO action this past week, beginning with electric vehicle battery producer Farasis Energy, which raised approximately $486m in an offering on the Shanghai Stock Exchange’s Star Market. It raised a reported $193m from investors including strategic partner Daimler earlier this month, and the corporate venturing arm of another carmaker, BAIC, is also among its shareholders.

On GUV, Paige, a US-based cancer pathology software spinout of Memorial Sloan Kettering Cancer Center, extended its series B round to $70m with commitments from Goldman Sachs Merchant Banking Division and Healthcare Venture Partners. Both were returning investors from previous tranches. The initial series B close last year had also featured Brey Capital, private investor Kenan Turnacioglu and undisclosed funds. Leo Grady, chief executive of Paige, told GUV: “The past year has underscored the need for pathology to adopt a digital workflow. As hospitals and labs look for solutions, they are seeing Paige as uniquely positioned: providing an enterprise solution for digital pathology images across sites and scanners while leveraging advanced cancer detection and characterisation solutions to provide additional information to the pathologist during diagnosis.”

Deals

RobinHood has seen demand for its share trading platform skyrocket during the Covid-19 lockdown, so much so it’s delayed the app’s UK launch. It has added 3 million new accounts and has followed that by adding $320m to a series F round that now stands at $600m. The company, which is backed by Alphabet unit CapitalG and Roc Nation, secured the capital at an $8.3bn valuation and has now raised a total of nearly $1.5bn in venture funding.

UiPath, a developer of robotic process automation technology that facilitates the automation of repetitive tasks like data entry, can also be said to be a company with a lockdown-relevant product. It has pulled in $225m through a series E round featuring Tencent that boosted its valuation from $7bn in May 2019 to $10.2bn post-money. CapitalG is also among UiPath’s investors, having first backed it in a 2018 series B round.

In Japan, ride hailing platform Mobility Technologies (MoT) has agreed up to $211m in corporate funding, with the lion’s share to come from mobile network operator NTT Docomo. The round included Dentsu and Tokyo Century and it shows the benefits of pivoting when the time is right. MoT began life as a taximeter software producer but has raised money from investors also including Toyota and Kakao Mobility since it switched tack.

Another Salesforce-backed company, Auth0, is also valued at $1.9bn, following a $120m series F round led by corporate VC vehicle Salesforce Ventures. Telstra Ventures also took part in the round, as did Deutsche Telekom’s DTCP unit, and the user authentication software provider intends to leverage Deutsche Telekom’s resources as it expands internationally. It has now secured more than $330m altogether.

Qumulo, developer of a cloud-based data management system, has completed a $125m series E round led by BlackRock that took its total funding above $350m. The cash was secured at a valuation of more than $1.2bn and it comes roughly two years after a series D round featuring disk drive manufacturer Western Digital. The cash will support product development and international growth.

Funds

We already had one huge fund but there was another last week: 23 biopharmaceutical companies have provided a total of almost $1bn in capital for AMR Action Fund, a vehicle tasked with helping to combat antimicrobial resistance by investing in companies developing new antibiotics. Those backers include Pfizer, Merck & Co and Johnson & Johnson, which are each supplying $100m. AMR Action Fund is slated to begin operations in the fourth quarter of 2020.

Exits

Small molecule cancer drug developer Relay Therapeutics has bagged $400m from its initial public offering, increasing the number of shares by more than a third and floating above its range. Its shaves have also risen post-IPO, providing a success story that’s badly needed for its largest investor, SoftBank Vision Fund. Although Vision Fund’s consumer-facing investments have been somewhat patchy, its life sciences deals seem to be paying off.

Banking software provider nCino has raised $250m in a flotation that saw it float a full $7 above its range. Its shares then nearly tripled in their first day of trading yesterday to give it a valuation of more than $1.9bn. The IPO is also a success for Salesforce, which owns a 12% stake having invested $72m in nCino between 2016 and late last year.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

10 June 2019 – Google Agrees $2.6bn Acquisition of Looker

The Big Ones

JD.com has agreed to lead a round for electronics recycler Aihuishou that will be more than $500m in size. The deal will also involve JD.com, an investor in the company since at least 2015, merging its second-hand e-commerce subsidiary, Paipai, with Aihuishou.

Google has agreed to purchase data analytics software provider Looker in a $2.6bn acquisition that will surely be one of the year’s largest.

SoftBank Vision Fund is still seeking out new forms of financing, and is reportedly in talks with banks such as Goldman Sachs over a $4bn debt financing package that will effectively use its stakes in Uber, Guardant Health and the soon-to-list Slack as its basis.

Healthcare-focused investment firm Deerfield Management added a partnership with Columbia University to its roster of academic biomedical alliances yesterday with the launch of an up to $130m investment vehicle, Hudson Heights Innovations.

Deals

Swiggy is battling Zomato for dominance in India’s online food delivery sector, and may be about to recruit a powerful ally in SoftBank.

Bordrin Motor is the latest Chinese smart electric vehicle developer to pull in big funding, securing $362m in a round led by a Sinochem vehicle called Silver Saddle Equity Investment Management.

Speaking of SoftBank, the telecommunications and internet group has also invested $200m in online consumer loan provider Creditas.

Hupu is still preparing to float in its home country of China, but before that, digital media company Bytedance has invested $182m in the sport-focused online media provider in return for a 30% stake.

Foursquare seems to have been around forever and has had some hiccups, but it’s raising more money than ever. Merchant bank Raine Group has invested $150m in the location-based app developer, whose existing backers include Naver and corporate venturing units OATV and Simon Ventures, and is using some of it to acquire location data-tracking software provider Placed from Snap, which bought the company for $135m two years ago.

SoftBank Vision Fund invested $100m in Brazilian logistics platform Loggi towards the end of last year and has now returned to lead another $100m round.

Endpoint security software provider SentinelOne has secured $120m in a series D round that included Samsung Venture Investment to boost its total funding to $230m.

Yellowbrick Data has raised $81m in series C funding from investors including BMW i Ventures, Siemens’ Next47 unit and Alphabet subsidiary GV to boost its overall funding to $173m.

Exits

Global Fashion Group, a consortium made up of investors including Rocket Internet, Access Industries and Tengelmann Ventures that oversees four fashion e-commerce marketplaces is looking to go public as early as next month.

Japanese digital business card platform Sansan has priced its initial public offering at the top of its range and is set to raise about $360m, including the over-allotment option, when it floats in Tokyo.

Adaptive Biotechnologies has filed to raise up to $230m in an initial public offering, following the inking of a collaboration deal with Genetech in December that could potentially be worth $2bn.

Another unicorn, fitness subscription service Peloton, has confidentially filed for an initial public offering. Its investors include Comcast NBCUniversal and Grace Beauty, and it was valued at more than $4.1bn when it last raised money, in August.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

12 June 2017 – Essential Houzz Deals and Much More

Deals

Houzz is reportedly nearing the close of a $400m round led by multi-family office Iconiq Capital that will value it at about $400m.

Essential, the smartphone startup founded by Andy Rubin, formerly head of Android at Google, has reportedly raised $300m at a valuation somewhere between $900m and $1bn.

Pinterest has raised $150m from existing investors – one of which may have been Rakuten – at a $12.3bn valuation.

Adaptive cybersecurity technology provider Illumio has raised $125m in a series D round that included a range of new and existing investors, and which reportedly valued it at more than $1bn pre-money.

Bitcoin and ethereum both reached new highs today, which makes it timely that crytocurrency management platform Coinbase is reportedly in talks to raise about $100m of new funding at a $1bn valuation.

Earlens, the developer of an advanced hearing aid that uses light to transmit sound, has closed a $73m series C round backed by medical device makers Medtronic and Cochlear alongside a $45m secured debt facility from CRG.

Tantan, the developer of a Chinese dating and social networking app that bears an, ahem, passing resemblance to Tinder, has pulled in $70m in a series D round led by YY. Tantan.

Coursera has boosted its total funding to $210m with a $64m series D round that, according to TechCrunch, valued it at $800m.

Logistics services provider Shansong Express, already backed by a subsidiary of Susquehanna International Group, has added Hearst Communications and Beijing Hualian Group to its shareholders thanks to a $50m series C+ round.

Funds

Fosun Kinzon Capital, the venture capital firm sponsored solely by conglomerate Fosun International, is set to invest $100m in Indian startups by the end of the calendar year, if an unnamed “top executive” is to be believed.

Legend Capital, the Chinese VC firm backed by Lenovo owner Legend Holdings, has reached the $448m final close of its latest fund.

On GUV, the Pittsburgh Revolution Fund is targeting a $200m close to support drug research teams that will form spinouts of University of Pittsburgh.

And on GGV, the government of Canada is planning to launch a C$400m ($296m) Venture Capital Catalyst Initiative to support small and medium-sized enterprises.

The government-owned Business Development Bank of Canada (BDC) is dedicating C$250m ($185m) towards growth equity over the next five years through investment arm BDC Capital.

AP2, a Swedish government-mandated pension fund, has injected $50m into the impact investment vehicle Rise Fund, which is aimed at a variety of global social challenges.

Irish state-owned export credit agency Enterprise Ireland is looking to raise €60m ($67m) with a regional development fund, according to the Irish Independent.

Exits

Mersana Therapeutics, which is working on antibody drug conjugates to treat cancer, has filed to raise $75m in an IPO that will allow Takeda and Pfizer to exit the company.

Delivery Hero has formally revealed it is seeking to go public this year, and is planning to issue more than $500m of shares in Germany and Luxembourg.

Aileron Therapeutics has filed for a $69m IPO that will support research and clinical development for a cancer treatment dubbed ALRN-6924.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

15 August 2016 – VR and Food Delivery Investments, GV People Moves and more

People

Friday was Bill Maris’s last day at GV, the corporate venturing unit he helped to set up for search engine Google in 2009. But it is a new start for David Krane, who is taking the CEO position at GV (formerly known as Google Ventures) and who will have a tough act to follow in Maris.

Eze Vidra, who helped GV set up its aborted European branch in 2014, has taken the chief innovation officer role at clinical trial connection platform TrialReach.

Vosik Shamsiev, a venture partner at Japan-based corporate venturing unit TEL Venture Capital since 2014, is leaving to pursue opportunities in Canada.

Citi’s strategic investment subsidiary has hired Travis Skelly from venture capital fund FinTech Collective as a senior vice-president. No announcement as yet on Debby Hopkins’ replacement.

Joydeep Bose joined Cisco from Intel Capital in 2007 and oversaw its corporate venturing activities in the Asia Pacific Japan region. D

Funds

Telstra and Telekom Indonesia form investment pact

Infosys lines up $15m Stellaris commitment

Exits

Wal-Mart has agreed to acquire Jet.com in a $3.3bn cash and share deal said to be the largest ever acquisition of an e-commerce company, and which will be marked down as a big win for investors including Alphabet and Alibaba.

CME Group looks like it’s secured a decent exit from deep learning technology provider Nervana Systems, just over a year after its corporate venturing vehicle, CME Ventures, took part in a $20.5m series B round.

In another sizeable acquisition, Myriad Genetics has agreed to buy precision medicine developer Assurex Health for up to $410m, giving exits to Mayo Clinic and Cincinnati Children’s Hospital Medical Center.

Naspers to squeeze out Citrus Pay acquisition

Protagonist Therapeutics has raised $90m in an IPO that gave exits to pharmaceutical firms Johnson & Johnson, Eli Lilly and Pharmstandard, which collectively held a 45% stake in the company.

Investments

CVRx, the producer of an implantable treatment for heart failure and resistant hypertension, has sealed $93m in equity funding.

Torax strengthens with $25m

Moderna Therapeutics closed the largest round ever by a VC-stage drug developer in January 2015, and one of the investors in that round, pharmaceutical company AstraZeneca, has invested another $140m to take its stake in the mRNA therapeutics company to 9%.

Turner has led a $45m round for female-focused digital media company Refinery29 as part of a strategic collaboration that will involve it developing video content for Turner’s TV channels.

The Walt Disney Company had been set to team up with Major League Baseball in a funding round for daily sports betting platform FanDuel last year but pulled out at the last minute. The two have now formed a partnership of a different kind, with Disney agreeing to pay $1bn for a 33% stake in BamTech, the online video streaming platform spun out by MLB. BamTech will also set up a paid video subscription platform for Disney subsidiary ESPN as part of the deal.

Andy Bechtolsheim (Sun cofounder and Google’s angel), and Diane Greene (VMware cofounder and Google board as head of cloud) along with corporates Major League Baseball, the Los Angeles Dodgers back Xperiel, a US-based provider of a mobile app development tool that works with Internet-connected equipment in sports stadiums and other facilities, $7m round.

Deliveroo raised $100m in November and has added $275m less than a year later with a series E round featuring Nokia Growth Partners.

Healthcare concierge service Accolade has added $70m from investors including Andreessen Horowitz and Madrona Venture Group to the $22.5m in series E funding it raised from McKesson Ventures and Independence Health last year, taking its overall financing to almost $150m.

Comcast targets Interactions in $56m round

Axial capitalises on Comcast backing to raise $14m

NextVR closes an $80m series B round at a pre-money valuation of $800m.

Kaltura has been at the online video game longer than NextVR and is gearing up for an IPO, raising $50m from Goldman Sachs’ Private Capital Investing group.

Yunnex, the Chinese developer of an advanced, connected point-of-sales system, has secured $45m in a series B round backed by one of its customers, fast food chain Ajisen Ramen.

Corporates dish up another $30m for iFood


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

22 February 2016 – Campbell Soup, Statoil, landscaping in China, MindMaze, Yello, Volvo, Google, Pie and more

Fundraising

Food technology developers like Impossible Foods and Juicero have raised some big rounds over the last year or two and that’s spurring food product makers to start entering corporate venturing in a significant way. General Mills set up a strategic investment unit late last year, and now Campbell Soup has joined the fray, putting $125m into an independently managed fund called Arce Venture Partners. Like Garden Fresh, the fresh food producer it acquired in June last year, the fund will link with the firm’s Campbell Fresh division.

Statoil launches $200 million venture fund for renewables

A range of Italy-based corporates – Menarini, RottaPharmBiotech, Elemaster and SapioLife – are among the limited partenrs for the first fund to be raised by venture capital firm Panakès Partners.

One corporate taking a more direct route is China-based garden landscaping company Palm Landscape Architecture, which is teaming with investment firm Hejun Zhengde for a fund that will focus on virtual and augmented reality technology. Palm has targeted $15m for the fund’s first close, and aims to use the technology to boost its town planning activities.

Investments

China’s media sector continues to grow and LeTV Sports, the sports streaming affiliate of Leshi Internet, is set to announce a $460m series B round.

As predicted, virtual and augmented reality continues to go from strength to strength this year. Following on from the $793m raised by Magic Leap earlier this month, MindMaze has secured $100m in a round led by UK-based conglomerate Hinduja Group. MindMaze’s technology is being utilised in the rehabilitation of stroke and brain-injury victims, but the company hopes to eventually deploy it for a variety of uses.

Japan-based digital financial services group SBI Holdings entered into a strategic partnership agreement with Korea-based mobile internet services company Yello Mobile in December that will involve the two helping each other expand in their respective nations. SBI has followed that up with a $30m investment in Yello, bringing the funding in its latest round, which values it at $4bn, to $73m.

Mobi Magic, a Chinese online security app developer, has raised $100m in a round co-led by cybersecurity company Qihoo360 Technology and Frees Fund, the VC fund formed last year by ex-IDG Capital Partners investor Li Feng. Qihoo 360 was also one of the investors that reportedly supplied Mobi Magic with $80m over the course of 2015.

Jana is an internet service provider that operates in emerging markets, pursuing a business model whereby commercial partners fund free access through advertising. Jana announced a $57m series C round today in which Verizon joined existing investors Publicis and Spark Capital, and plans to expand into China to add to the 30 million users it has across Africa, Asia and Latin America.

Exits

Volvo’s corporate venturing unit invested an undisclosed amount in strategic partner Lytx in 2013, and it has now exited the driving safety technology producer through an acquisition by private equity firm GCTR. Lytx, which had raised upwards of $160m in debt and equity, was purchased for $500m.

Google today announced that it is building its first engineering team devoted to Southeast Asia and toward that end has acquired Pie, a Slack-like team communications service based in Singapore.

Metalysis is today announcing a combined investment of £20 million from Woodford Patient Capital Trust, managed by Neil Woodford, one of Britain’s most prominent fund managers, and Iluka Resources, an existing investor in Metalysis.  Iluka increases its interest in the Company to 28.8% as a result of this funding round.

Metalysis’ technology produces metal powders – primarily titanium, tantalum and bespoke alloys – at lower cost with reduced environmental impact.

Cybersecurity software developer Cylance said today that it has entered into a strategic partnership with In-Q-Tel.

University of Oxford Isis Fund II, managed by Parkwalk, has invested in Mind Foundry, an Oxford Spin-out company with technology that uses advanced machine learning algorithms to help organisations solve problems by unlocking insights hidden deep within their big data.